TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
BioNordika (Sweden) AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover | 5,437 | 4,828 | 5,580 |
Financial expenses | 0 | 0 | 0 |
Earnings before taxes | 575 | 654 | 996 |
EBITDA | 577 | 676 | 1,021 |
Total assets | 1,400 | 1,803 | 2,267 |
Current assets | 1,247 | 1,739 | 2,209 |
Current liabilities | 937 | 1,365 | 1,791 |
Equity capital | 463 | 438 | 476 |
- share capital | 9 | 9 | 10 |
Employees (average) | 14 | 13 | 12 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency | 33.1% | 24.3% | 21.0% |
Turnover per employee | 388 | 371 | 465 |
Profit as a percentage of turnover | 10.6% | 13.5% | 17.8% |
Return on assets (ROA) | 41.1% | 36.3% | 43.9% |
Current ratio | 133.1% | 127.4% | 123.3% |
Return on equity (ROE) | 124.2% | 149.3% | 209.2% |
Change turnover | 595 | -300 | 252 |
Change turnover % | 12% | -6% | 5% |
Chg. No. of employees | 1 | 1 | 2 |
Chg. No. of employees % | 8% | 8% | 20% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.